The ABCA1 gene helps cells move cholesterol and certain fats onto HDL, often called “good” cholesterol, so they can be carried out of tissues. When this gene does not work well, cholesterol can build up inside cells and HDL levels can be very low. Some people with more disruptive ABCA1 variants develop Tangier disease, which can cause enlarged orange tonsils, numbness or tingling, and a higher chance of early heart disease. Many variants in this gene have little effect, while a few may change how the body handles cholesterol.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the working parts of cells. Other genes mostly help determine when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can visit the LearnHub.
Overview
ABCA1Gene function
What if the gene works
The ABCA1 gene helps cells move cholesterol and certain fats to HDL, often called “good” cholesterol. This supports cholesterol balance and helps the body carry extra cholesterol away from tissues.
Risk
What if the gene does not work
Variants in the ABCA1 gene can leave HDL cholesterol very low and let cholesterol build up in tissues. Milder variants may cause familial HDL deficiency, while more severe variants can lead to Tangier disease and can raise early cardiovascular disease risk.
Treatment
What does that mean for your treatment
No treatment, management approach, or drug choice tied specifically to a pathogenic or loss of function variant in the ABCA1 gene is currently established in clinical guidelines. The ABCA1 gene is being studied as a drug target and biomarker in cholesterol and artery disease research.
Conditions associated with ABCA1
Gene function
What if the gene works
Cells constantly handle cholesterol and other fats as they grow, repair, and renew their outer membrane. The ABCA1 gene supports this daily traffic at the cell surface. Its main job is to help move certain fats out of cells so they can be carried away in HDL, often called good cholesterol.
The ABCA1 gene helps cells move extra cholesterol out to their outer surface. This is a key step in how the ABCA1 gene helps remove cholesterol from cells and keeps everyday fat handling in balance.
It transfers cholesterol and phospholipids (fats that make up cell membranes) to APOA1, a carrier protein in HDL. This loading step helps your body form the first HDL particles, often called good cholesterol.
By moving selected fats across the cell surface, this gene supports the normal makeup of cell membranes. That helps cells keep a stable outer barrier and handle routine signaling and transport.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not produce any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ABCA1 gene affect protein function by weakening how the transporter folds, reaches the cell surface, or transfers cholesterol and phospholipids to APOA1. Some changes leave partial activity, while more severe variants can cause little or no transport. This range in functional impact often shapes whether ABCA1 related conditions are milder or appear earlier and more clearly, especially when both gene copies carry a more disruptive variant.
How variants are linked to conditions
Pathogenic variants in the ABCA1 gene cause Tangier disease and can also cause familial HDL deficiency, so ABCA1 gene variants linked to conditions most clearly affect HDL, often called “good” cholesterol. People with these conditions often have very low HDL levels. Some may develop enlarged orange tonsils, numbness, liver or spleen enlargement, or earlier cardiovascular disease. Common ABCA1 variants have also been associated with differences in cholesterol levels and may slightly influence heart disease risk, but they do not guarantee disease.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most of these variants do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ABCA1, risk is shaped mainly by the specific gene change you carry and whether it affects one or both copies of the gene. Beyond that, there is no broadly confirmed evidence that particular lifestyle or environmental factors change ABCA1-related risk itself, although smoking, diabetes, and high blood pressure can still add to overall heart risk.
Inheritance of ABCA1 variants
The inheritance pattern for ABCA1-related conditions can differ depending on the specific finding. Tangier disease, the best known condition linked to the ABCA1 gene, usually follows an autosomal recessive pattern, which means a child inherits one ABCA1 variant from each parent. Some people with a variant in just one copy of the ABCA1 gene have very low HDL cholesterol, so this can appear across generations in a dominant or codominant way. This is the main way doctors explain how ABCA1 variants are inherited in families.
What does my ABCA1 result mean for my family?
ABCA1 results can have different family implications depending on the condition linked to the variant. For Tangier disease, which usually happens when a child inherits a changed copy from each parent, close relatives may be carriers and siblings may also be affected. Some ABCA1 variants linked to very low HDL cholesterol can affect people with one changed copy, so parents, brothers, sisters, and children may also share the result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the ABCA1 gene usually uses a blood or saliva sample, which a lab analyzes to look for DNA changes linked to inherited cholesterol conditions. Results may show a clearly relevant variant, no relevant variant, or a variant of uncertain significance, meaning the finding is not yet clearly understood.
When should I consider getting a genetic test?
Consider ABCA1 genetic testing if blood tests show very low HDL, the “good” cholesterol, especially with a family history of the same finding, early heart disease, or signs such as enlarged orange tonsils, numbness, or an enlarged liver or spleen. Testing can help confirm Tangier disease or a related inherited cause of very low HDL.
A genetic result is only one part of your health story
A genetic finding can be informative, but the amount it explains varies with the condition and the kind of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic result can offer a definite answer. In areas like medication response, genetic findings can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get a stronger effect, a weaker effect, or more side effects because their bodies absorb, break down, transport, or respond to the drug differently. This kind of variation is common and can influence how well a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect response to medications. It examines relationships between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can help support more informed, individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the ABCA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about medications, side effects, or treatment changes are best discussed with your doctor. Some research has looked at whether ABCA1 changes may affect response to certain cholesterol-related treatments, but this is not a routine part of care.
History
Throughout history, people have described features that hinted at this gene. In the 1960s, doctors studying families from Tangier Island in Virginia noticed people with very low HDL cholesterol and unusual orange tonsils, a condition later called Tangier disease. That rare condition became a major clue in cholesterol research. Building on this early work, scientists identified the ABCA1 gene in 1999 and showed that harmful variants in it were the cause of Tangier disease. This discovery helped explain how the body handles cholesterol at a cellular level and reshaped research on HDL, often called “good” cholesterol. Since then, the ABCA1 gene has remained an important part of studies on inherited lipid conditions and heart health.